SNORA60 and diffuse large B-cell lymphoma: Additionally, we found potentially harmful roles of SNORD1A and SNORA60 in DLBCL with higher expression levels in high‐risk cohorts; moreover, up‐regulation of SNORD1A and SNORA60 correlated with an unfavorable outcome in DLBCL patients.